Intrinsic Value of S&P & Nasdaq Contact Us

NewcelX Ltd. NCEL NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CH • USD

SharesGrow Score
66/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — NCEL

NewcelX Ltd. (NCEL) has a market capitalization of $1.13M and trades at $2.50. The 52-week range is 1.83-30.8.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-26.30.

The stock has a beta of 0.57, operates in the Healthcare sector.

Trading Data
Current Price$2.50
52-Week Range1.83-30.8
Volume10.76K
Avg Volume (30D)35.1K
Market Cap$1.13M
Beta (1Y)0.57
Company
IPO Date2025-10-24
Employees11
CEORonen Twito
CountryCH
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINCH1442297896
CUSIPH5835A109
Income (Latest Year)
Gross Profit$-3.32K
EBITDA$-3.63M
Operating Income$-4.38M
Net Income$-1.98M
EPS$-26.30
EPS Diluted$-26.30
Shares Outstanding$75.3K
Balance Sheet (Latest Year)
Total Assets$2.23M
Current Assets$2.23M
Cash & ST Investments$1.67M
Total Liabilities$826.76K
Net Debt$-1.67M
Total Equity$1.41M
Valuation Ratios
P/E Ratio-0.1
P/B Ratio0.8
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message